Olema Pharmaceuticals, Inc. (OLMA) Tops Q3 EPS by 3c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q3 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• Olema Pharmaceuticals (OLMA) PT Lowered to $36 at H.C. Wainwright
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c